Interleukins and miRNAs intervene in the early stages of diabetic kidney disease in Type 2 diabetes mellitus patients

Biomark Med. 2019 Dec;13(18):1577-1588. doi: 10.2217/bmm-2019-0124. Epub 2019 Oct 30.

Abstract

Aim: The involvement of proinflammatory interleukins (IL) in diabetic kidney disease of Type 2 diabetes mellitus (DM) patients was studied in relation to a particular miRNA profile. Materials & methods: A total of 117 patients with Type 2 DM and 11 controls were enrolled in a case series study. Serum and urinary ILs and miRNAs were assessed. Results: IL-1α correlated with miRNA21, 124, estimated glomerular filtration rate (eGFR) and negatively with miRNA125a and 192; IL-8 with miRNA21, 124, eGFR and negatively with miRNA125a, 126 and 146a; IL-18 with miRNA21, 124 and negatively with miRNA146a, 192, eGFR. Conclusion: There is an association between specific serum and urinary ILs and serum and urinary miRNAs profiles in the inflammatory response in Type 2 DM patients with diabetic kidney disease.

Keywords: albuminuria; diabetes mellitus; interleukins; miRNAs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Diabetes Mellitus, Type 2 / complications*
  • Diabetic Nephropathies / blood*
  • Diabetic Nephropathies / etiology
  • Diabetic Nephropathies / genetics
  • Diabetic Nephropathies / urine*
  • Female
  • Humans
  • Interleukin-18 / blood
  • Interleukin-18 / urine
  • Interleukins / blood*
  • Interleukins / urine*
  • Male
  • MicroRNAs / blood*
  • MicroRNAs / genetics
  • MicroRNAs / urine*
  • Middle Aged
  • Young Adult

Substances

  • IL18 protein, human
  • Interleukin-18
  • Interleukins
  • MicroRNAs